BackNew Frontier Health Overview

New Frontier Health Other Current Liabilities

Track New Frontier Health's other current liabilities ($430M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$430.48M
52.25% YoYΔ $-471.00M vs prior year quarter

Peer trimmed avg / median

Loading

New Frontier Health Other Current Liabilities History

Loading

New Frontier Health vs. peers: Other Current Liabilities Comparison

Loading

New Frontier Health Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

New Frontier Health (NFH) FAQ

New Frontier Health posts a other current liabilities of $430M as of December 2020. That compares with $900M in the prior-year period — down 52.2% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, New Frontier Health's other current liabilities was $900M. The latest reading is $430M — a 52.2% year-over-year decrease (period ending December 2020). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of New Frontier Health's financial statement story. At $430M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NFH's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; New Frontier Health's other metric pages and overview cover the third.

Judging New Frontier Health against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in other current liabilities easier to interpret. Start with $430M here, then scan peer and history charts to see if the gap is persistent.